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Abstract
In the budding yeast Saccharomyces cerevisiae, the lysine acetyltransferase NuA4 has been linked to a host of cellular
processes through the acetylation of histone and non-histone targets. To discover proteins regulated by NuA4-dependent
acetylation, we performed genome-wide synthetic dosage lethal screens to identify genes whose overexpression is toxic to
non-essential NuA4 deletion mutants. The resulting genetic network identified a novel link between NuA4 and septin
proteins, a group of highly conserved GTP-binding proteins that function in cytokinesis. We show that acetyltransferase-
deficient NuA4 mutants have defects in septin collar formation resulting in the development of elongated buds through the
Swe1-dependent morphogenesis checkpoint. We have discovered multiple sites of acetylation on four of the five yeast
mitotic septins, Cdc3, Cdc10, Cdc12 and Shs1, and determined that NuA4 can acetylate three of the four in vitro. In vivo we
find that acetylation levels of both Shs1 and Cdc10 are reduced in a catalytically inactive esa1 mutant. Finally, we determine
that cells expressing a Shs1 protein with decreased acetylation in vivo have defects in septin localization that are similar to
those observed in NuA4 mutants. These findings provide the first evidence that yeast septin proteins are acetylated and
that NuA4 impacts septin dynamics.
Citation: Mitchell L, Lau A, Lambert J-P, Zhou H, Fong Y, et al. (2011) Regulation of Septin Dynamics by the Saccharomyces cerevisiae Lysine Acetyltransferase
NuA4. PLoS ONE 6(10): e25336. doi:10.1371/journal.pone.0025336
Editor: Kevin G. Hardwick, University of Edinburgh, United Kingdom
Received July 7, 2011; Accepted September 1, 2011; Published October 3, 2011
Copyright:  2011 Mitchell et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research is funded by the Canadian Cancer Society (grant # 20309) and an Early Researcher Award from the Ontario Government to K.B. K.B. is a
Canada Research Chair (CRC) in Chemical and Functional Genomics. D.F. is a CRC in Proteomics and Systems Biology and J.F.C. is a CRC in Structural Biology and
Epigenetics. L.M. was supported by a Canada Institute for Health Research Ph.D. scholarship. A.L. was supported by a Natural Sciences and Engineering Research
Council of Canada M.Sc Scholarship. J.-P.L. was supported by an Ontario Graduate Scholarship. http://www.cihr-irsc.gc.ca/. http://www.nserc-crsng.gc.ca/. http://
www.hrsdc.gc.ca/eng/workplaceskills/foreign_workers/reschair.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kbaetz@uottawa.ca
Introduction
Lysine acetylation is traditionally associated with histone
proteins and the regulation of a variety of chromatin-based
cellular processes [1]. More recently, systematic efforts have
revealed that thousands of additional proteins are acetylated in vivo,
dramatically altering our view of the abundance of this
modification and the multitude of cellular pathways it impacts
[2,3,4,5]. The next major challenge will be to connect lysine
acetyltransferase (KAT) enzymes to their substrates and target
lysine residues in order to understand the biological consequences
of acetylation.
NuA4 is a KAT complex in the budding yeast S. cerevisiae [6]
whose function has been linked to a variety of cellular processes
including transcription [7], DNA repair [8], chromosome segre-
gation [9], cell cycle control [10,11], stress response [12,13],
vesicle-mediated transport [13] and gluconeogenesis [14]. Accord-
ingly, the orthologous human complex, Tip60, which is highly
conserved both structurally and functionally [15], is known to
be misregulated in a number of human pathologies, including
Alzheimer’s disease [16] and cancer [17]. NuA4 is a multi-subunit
complex, composed of the essential catalytic subunit Esa1 [6], five
other essential subunits Act1, Arp4, Epl1, Swc4, Tra1, and seven
non-essential subunits Eaf1, Eaf3, Eaf5, Eaf6, Eaf7, Yaf9, and
Yng2. Molecular dissection has revealed NuA4 to be modular in
nature, and that assembly of its multiple sub-complexes depends
on the Eaf1 subunit [18]; in the absence of Eaf1, NuA4 complex
integrity is disrupted [13]. The Eaf3/Eaf5/Eaf7 and Act1/Arp4/
Swc4/Yaf9 sub-complexes, along with the final subunit, Tra1,
have been proposed to function as a recruitment module that
targets the acetyltransferase activity of the complex, contained in
the final sub-complex (Esa1/Epl1/Yng2/Eaf6), also known as
Piccolo NuA4 (PicNuA4), to specific loci [7]. Moreover, PicNuA4
exists as a discrete, acetyltransferase-competent complex in wild
type yeast cells independent of the larger NuA4 complex, and is
thought to globally and non-specifically acetylate histones [19].
Importantly, the non-essential proteins Eaf1 and Yng2 are each
required for Esa1’s acetyltransferase activity on histone targets in
vivo [9,20,21] and can therefore serve as genetic tools for studying
NuA4-related functions.
In vivo the most thoroughly characterized acetylation targets of
Esa1 include the histone proteins H4 [6,22,23], and the H2A
variant Htz1 [20,21,24]. Notably, Esa1 must be associated with
PicNuA4 or the full NuA4 complex to be catalytically active on
nucleosome-bound histones [19,22]. While a plausible explanation
to account for the many and diverse cellular functions of NuA4 is
that the complex acts as a master transcriptional regulator in the
cell via histone acetylation alone, microarray analysis suggests the
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[9,12,25]. One notable exception is the positive contribution
NuA4 makes in rDNA gene transcription via histone H4
acetylation at ribosomal promoters [26]. An alternative hypoth-
esis, which is strongly supported by multiple lines of evidence, is
that NuA4 mediates many of its diverse cellular effects through the
acetylation of non-histone targets. To date, two non-histone NuA4
acetylation targets have been characterized in vivo: the NuA4 and
PicNuA4 subunit Yng2 [27], and the gluconeogenesis regulator
Pck1 [14]. In these two cases, Esa1-dependent acetylation
regulates protein stability and enzymatic activity, respectively.
Similarly, several non-histone acetylation targets have been
documented in vivo for the human NuA4 complex, Tip60,
including p53, c-myc, and ATM kinase [28,29]. Finally, to
explore the possibility that NuA4 acetylates a broad range of both
nuclear and non-nuclear proteins, Lin et al. [14], using a protein
acetylation microarray, identified 91 novel in vitro substrates of
NuA4 and further confirmed 13 non-chromatin proteins to be
substrates of NuA4 in vivo. However, the full extent and the
biological consequences of NuA4 dependent in vivo acetylation
have yet to be established.
To date, NuA4 function has been assessed extensively using
genome-wide synthetic lethal (SL) genetic interaction screens
[13,27,30,31,32,33], which highlight genetic redundancy between
pairs of hypomorphic gene mutations. Though highly informative
in regards to biological function, SL screens generally identify
proteins that function in parallel rather than direct pathways [34].
Here we have taken advantage of a new genome-wide genetic
screen called synthetic dosage lethal (SDL) profiling, which
systematically assesses the effect of gene overexpression in a
mutant background [35]. It is now well established that SDL and
SL genetic interactions probe mechanistically unique genetic
relationships [35,36,37], indicating SDL profiling can be used as a
complementary tool to predict novel processes impacted by query
genes of interest. Further, based on the premise that an increased
amount of inappropriately modified substrate may cause a
measurable fitness defect specifically in an enzyme mutant
background, genome-wide SDL screens have proven successful
in identifying downstream targets of kinases [35,37].
Thus, in an attempt to discover novel pathways and putative
substrates directly regulated by NuA4, we have generated SDL
profiles for the seven non-essential NuA4 deletion mutants. Our
network uncovers a novel connection between NuA4 and septin
proteins, a group of highly conserved proteins that function in
cytokinesis in many organisms [38]. We discover that acetylation-
deficient eaf1D cells develop elongated buds and have defects in
septin dynamics. Further, we identify multiple acetyl lysine
residues on four of the five mitotic septin proteins, that NuA4
can acetylate three septin proteins in vitro, and that the acetylation
level of at least two septin proteins is dependent on Esa1 in vivo.
Finally, we focus on the biological consequence of Shs1 acetylation
and determine that cells expressing an unacetylable Shs1-HA3
fusion protein displays bud morphology and septin localization
defects similar to those observed in NuA4 mutants suggesting a
direct relationship between septin acetylation and septin dynamics.
Importantly, this work establishes a new role for NuA4 in the
regulation of septin dynamics and identifies acetylation as a novel
post-translational modification regulating septin proteins.
Materials and Methods
Yeast strains and plasmids
Yeast strains used in this study are described in Table S1
and plasmids generated for this study listed in Table S2. The
galactose-inducible overexpression array [35] was a gift from
Brenda Andrews. Genomic deletion or epitope tag integrations
made for this study were designed with PCR-amplified cassettes as
previously described and confirmed by PCR analysis [39].
SDL screening
Media used for the genome-wide SDL screens was prepared as
described [35], except that as the five non-essential NuA4 deletion
mutants used for genome-wide SDL analysis were linked to the
dominant selectable marker NAT, diploid and final haploid
selections were achieved using clonNAT (Werner Bioagents,
5.0000) at a final concentration of 100ug/mL. The SDL library
(,5300 yeast strains) was initially arrayed in duplicate at a density
of 1536 colonies per plate, yielding 9 high-density library plates
maintained on medium lacking uracil to select for the presence of
the overexpression plasmids. All replica pinning steps were carried
out as described [35] using a Singer RoToR HDA (Singer Ins-
trucments). Genome-wide SDL screens were performed in tri-
plicate at 25uC using the following query strains: eaf1D (YKB622),
eaf3D (YKB995),eaf5D (YKB852),eaf6D (YKB623),eaf7D (YKB853).
For the final scoring analysis, plate images were acquired using the
ChemiDoc XRS Molecular Imaging System (BioRad) two daysafter
pinning onto synthetic medium lacking uracil and containing either
glucose or galactose as the sugar source. Images were analyzed using
an in-house automated scoring method. SDL interactions that
appeared in a list of ‘‘toxic genes’’, whose overexpression alone is
known to kill wild type cells [35], were discarded from further
analysis. For each query strain, interactions identified in at least two
screens were confirmed by direct transformation followed by serial
spot dilution assays. All SDL and synthetic dosage sick (SDS)
interactions were then directly tested in all seven non-essential NuA4
deletion mutant backgrounds, eaf1D (YKB44), eaf3D (YKB1162),
eaf5D (YKB658), eaf6D (YKB504), eaf7D (YKB530), yaf9D (KYB464)
and yng2D (YKB494), by direct transformation followed by streak
test.
Serial spot dilution assay to confirm SDL interactions
Wild type and NuA4 mutant strains, transformed with
galactose-inducible overexpression plasmids or an empty vector
control (pRS416) using traditional methods [40], were grown to
mid-log phase in SD-URA liquid medium at 25uC. Ten-fold serial
dilutions (OD600=0.1, 0.01, 0.001, 0.0001) were spotted onto
medium lacking uracil and containing either galactose or glucose.
Plates were incubated for 5 days at 25uC and images were
collected using the ChemiDoc XRS Molecular Imaging system
(Biorad).
Microscopy
All cells were grown to mid-log phase in YPD supplemented
with adenine unless otherwise noted. For imaging of fixed cells,
samples were prepared with paraformaldehyde as previously
described [41] and Z-stack images were collected (0.3 mm steps)
across 5–6 mm. For in vivo time-lapse studies, cells were re-
suspended at high density in SD media and then spread on
agarose pads prepared with synthetic complete media on standard
microscope slides prepared as described [42], except coverslips
were sealed with VALAP (1 vasoline: 1 lanolin: 1 paraffin). Live
cell imaging was performed at room temperature and Z-stacks
(0.5 mm steps) were collected across 20 mm every 5 minutes for
wild type cells up to 2 hours and every 15 minutes for eaf1D cells
up to 6 hours. For quantification, only the mother cells were
tracked post cytokinesis. Bud morphology and septin localization
was scored for 15 wild type cells from a single experiment (1 field
of view) and from 4 unique experiments for eaf1D cells (between 4
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collect data for 43 cells). Microscopy was performed using a Leica
DMI 6000 florescent microscope (Leica Microsystems GmbH,
Wetzler Germany), equipped with a Sutter DG4 light source
(Sutter Instruments, California, USA), Ludl emission filter wheel
with Chroma band pass emission filters (Ludl Electronic Products
Ltd., NY, USA) and Hamamatsu Orca AG camera (Hamamatsu
Photonics, Herrsching am Ammersee, Germany). Images were
collected and analyzed using Velocity 4.3.2 Build 23 (Perkin
Elmer). Analysis was performed on images collapsed into two
dimensions using the ‘‘extended focus’’ option in Velocity.
GFP immunopurification and in vivo acetylation
All cells were grown to mid-log phase in YPD supplemented
with adenine unless otherwise noted in 50–100 mL cultures.
Lysate preparation and immunopurifications were carried out as
described for septin TAP immunopurifications, except lysates were
sonicated 1610 sec and 20 mL of GFP-trap magnetic beads
(Chromotek, GTM-20) was added to 10 mg of whole cell lysate.
Proteins were eluted in 25 ml of 2x loading dye (50 mM Tris,
pH 6.8, 2% SDS, 0.1% bromophenol blue, 200 mM beta-2-
mercaptoethanol, 10% glycerol) with heating at 65uC for 10
minutes. Western blotting was performed using a semi-dry transfer
apparatus from Biorad (Trans-Blot SD Semi Dry Electrophoretic
Transfer Cell; 170-3940) and buffers recommended by the
manufacturer. Protein transfer was performed for 1 hour using
constant milliamps (mA) based on the following calculation:
0.8mA x area of gel x # of gels. Acetylation was detected using
two anti-acetyl lysine antibodies at the following dilutions: Cell
Signaling, 1/500 (9681); Upstate 1/1000 (06-933). Other primary
antibodies used were: a-Act1 1/1000 (Novus Biologicals, NB600-
505); a-MYC 1/1000 (Roche, 11667149001); a-G6PDH 1/10000
(Sigma, A9521), a-HA 1/1000 (Covance, MMS101P); a-GFP 1/
1000 (Roche, 11814460001); 1/1000 a-hyperacetylated histone
H4 (06-946). All blocking, primary, and secondary antibody
incubations were performed with 5% milk dissolved in PBS plus
0.1% Tween20 (PBS-T), except the Cell Signaling anti-acetyl
lysine antibody, in which the manufacturer’s recommendation of
5% BSA in TBS plus 0.1% Tween20 was followed. Primary
incubations were carried out overnight at 4uC and secondary
incubations at room temperature for 2 hours. Secondary antibodies,
all used at a dilution of 1/5000, were peroxidase-conjugated goat
anti-rabbit IgG (Chemicon; AP307P), and peroxidase-conjugated
goat anti-mouse IgG (Bio-Rad; 170-6516) where appropriate.
Chemiluminescence was detected using Immobilon Western
Chemiluminescent HRP substrate (Millipore; WBKLS0500) and
developed on a ChemiDoc XRS system (Biorad; 170-8070). All
experiments were repeated a minimum of three times and a
representative image is shown.
Septin TAP Immunopurification and radioactive in vitro
KAT assay
Septin protein complexes were isolated from exponentially
growing yeast cultures via single step affinity purification of protein
A, one epitope of the tandem affinity purification (TAP) tag. Cells
from 300 ml of mid-log phase culture grown in YPD at 30uC were
collected by centrifugation, washed in 25 mL of ice-cold water and
transferred to 1.5 mL Eppendorf tubes where they were flash
frozen on dry ice. Cell pellets were re-suspended in 300 mL of lysis
buffer (100 mM HEPES pH 8.0, 20 mM magnesium acetate,
10% glycerol (V/V), 10 mM EGTA, 0.1 mM EDTA, 300 mM
sodium acetate, and fresh protease inhibitor cocktail (Sigma,
P8215)) plus an equal volume of glass beads, and cells were lysed
through vortexing (six 1-minute blasts with incubation on ice
between vortexing). Lysates were subjected to sonication
(3620 sec; 1 minute incubation on ice between each pulse) using
a Misonix Sonicator 3000 at setting four. Prior to centrifugation
(10 min, 3000 rpm, 4uC), Nonidet P-40 was added to a final
concentration of 1%. Forty milligrams of whole cell extract was
incubated with 100 mL of magnetic beads (Invitrogen, 143.02D)
cross-linked to rabbit immunoglobulin (IgG) (Chemicon, PP64) as
per the manufacturer’s instructions. Following 2 hours of end-
over-end rotation at 4uC, the beads were collected on a magnet
and washed 3 times with 1 mL of ice cold wash buffer (100 mM
HEPES pH 8.0, 20 mM magnesium acetate, 10% glycerol (V/V),
10 mM EGTA, 0.1 mM EDTA, 300 mM sodium acetate, 0.5%
Nonidet P-40). The KAT assay was performed with the septins
proteins bound to the magnetic beads. To the septin-magnetic
bead matrix was added 3 mL of 5X KAT buffer (250 mM Tris
pH 8.0, 250 mM NaCl, 25 mM MgCl2, 5 mM DTT), 0.5 mCi of
[
3H]-acetyl coenzyme A (Perkin-Elmer, NET290L050UC), and
5 mL of NuA4, purified from yeast cells (described below) in a final
volume of 15 mL. The reaction was incubated for 1 hour at 30uC
with end-over-end rotation. As the NuA4 preparation included the
TEV enzyme, TAP-tagged septin proteins were cleaved from the
magnetic beads during the KAT assay. An equal volume of 2x
loading dye (100 mM Tris, pH 6.8, 4% SDS, 0.2% bromophenol
blue, 200 mM b-2-mercaptoethanol, 20% glycerol) was added and
the samples heated at 65uC for 10 minutes. Proteins were
separated by SDS-PAGE (7.5%). Following Coomassie staining
and destaining, an image was taken of the gel. Next, the gel was
treated for fluorography, dried, and exposed to film for 1 month at
280uC. To ensure NuA49s activity, a control reaction was
performed on 2 mg of chicken core histones (Upstate, 13-107)
using 3 mL of purified NuA4 and 5 mCi of [
3H]-acetyl coenzyme A
in a final volume of 10 mL. This sample was processed as described
above except proteins were separated using 15% SDS-PAGE.
Purification of NuA4 from yeast for in vitro KAT assays
Endogenously TAP-tagged Esa1 was used to purify NuA4 from
yeast cells as described [13], except the immunopurified products
were eluted from magnetic beads by enzymatic cleavage in TC
Buffer (50 mM Tris, pH 8.0, 1 mM DTT, 0.1% Nonidet P-40,
150 mM NaCl, 10% glycerol) using tobacco etch virus (TEV;
prepared in-house). Briefly, cells from 1 L of exponentially
growing culture (in YPD, at 30uC) were lysed and NuA4 was
purified in a single step using magnetic beads coupled to IgG.
After washing, the NuA4-bead matrix was resuspended in TC
buffer (100 mL) to which was added 20 mL of TEV. The cleavage
reaction was incubated overnight at 4uC with end-over-end
rotation. Finally, the supernatant was isolated from the beads,
aliquoted, and stored at 280uC. The purity of the NuA4
preparation was assessed by silver stain using 2 mL of TEV-
cleaved sample separated by SDS-PAGE (7.5%) and its acetyl-
transferase activity was tested in an in vitro KAT assay (described
above) using 2 mg of chicken core histones (Upstate, 13-107) and
2 mg of acetyl coenzyme A (Sigma, A2056) in a final volume of
15 mL. The acetylation signal was assessed by Western blot using
an anti-acetyl lysine antibody (Upstate, 06-933).
Detection of acetylated lysine residues by mass
spectrometry
TAP-tagged septin proteins were immunopurified as described
above for the radioactive KATs assays. One half of each sample
was subjected to an in vitro NuA4 KAT assay, as described above,
except 1 mg of unlabelled acetyl coenzyme A (Sigma, A2056) was
added. Samples were resolved on SDS-PAGE gel, silver stained
and bands excised. Following in-gel digestion with trypsin, samples
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system (Agilent Technologies) coupled to either an LTQ or an
LTQ-Orbitrap XL spectrometer (Thermo-Electron) as indicated
(Table S5). Acetylated lysine residues on septin proteins were
identified as previously described [4]. MS/MS corresponding to
putative lysine acetylation sites were all manually validated.
Cloning and mutagenesis of SHS1
SHS1 was C-terminally epitope tagged (HA3) at its endogenous
genomic locus using standard homologous recombination tech-
niques [39]. The SHS1-HA3 gene fusion plus endogenous
promoter were subsequently amplified from isolated genomic
DNA using Phusion Polymerase (Finnzyme, F-530S) with a
forward primers localized ,500 base pair upstream of the
SHS1-HA3 start site and a reverse primer that bound 39 of the
transcriptional terminator sequence of the HA3 coding sequence.
Each primer contained a 59 SalI recognition sequence, thus the
resulting PCR product was digested with SalI, gel purified (Qiagen,
28704), and ligated into the pRS415 vector [43] that was
previously digested with SalI and treated with calf intestinal
phosphatase (NEB, M0290S). Ligation reactions were carried out
overnight with T4 DNA ligase at 16uC (NEB, M0202S), and then
transformed into competent E.coli DH5alpha cells prepared in-
house. The final clone was fully sequenced. HA3 and C-terminal
truncation mutants were generated as described [44]. Point
mutations were generated using the QuikChange Multi Site-
Directed Mutagenesis Kit (Agilent, 200514). The successful
introduction of all point mutations was confirmed by sequencing.
Results
The NuA4 synthetic dosage lethal network
To elucidate pathways regulated by the NuA4 lysine acetyl-
transferase complex and to discover putative substrates, we
identified SDL interactions for the seven non-essential NuA4
subunits. Genome-wide SDL analysis was performed with five
NuA4 query genes (eaf1D, eaf3D, eaf5D, eaf6D, eaf7D) using
synthetic genetic array (SGA) technology [35,45]. Any gene
whose overexpression caused an SDL phenotype in at least one
NuA4 query strain was directly tested in all non-essential
NuA4 deletion mutant backgrounds, including the remaining
two, yaf9D and yng2D. The resulting NuA4 SDL genetic network
encompasses 173 interactions among 89 genes, of which 16%
(27/173) are SDL interactions and the remainder are SDS
(synthetic dosage sick) interactions. (Figure 1A, Table S3). Similar
to previous NuA4 SL screens [13,27,30,31], our SDL analysis
successfully identified biologically relevant genes in cellular
processes known to be impacted by NuA4, such as transcription
[7], DNA damage [8], cell cycle progression [10,11], and the stress
response [12,13]. Given that the genetic underpinnings of SDL
and SL interactions are unique [35,37], as expected there was
only minimal overlap between the NuA4 SDL interactions with
previously published genome-wide SL interactions (Figure 1B and
Table S4) [13,27,30,32,33].
As most non-essential NuA4 subunits participate in multiple
protein complexes in yeast [7], we were particularly interested in
genes that displayed SDL interactions with multiple NuA4
deletion mutants. We grouped interacting genes with respect to
the three major functional sub-complexes within NuA4: Eaf1, the
subunit required for complex assembly [13,18]; Yng2 and Eaf6 as
subunits of PicNuA4 [13,19]; and the remaining non-essential
subunits as components of the recruitment domain [7] (Figure 1A).
While more than half of genes in the network interacted with
mutants from at least two sub-complexes (47/89), 15 genes
displayed SDL interactions with at least one NuA4 mutant from
each of the sub-complexes (Figure 1A). We focused our attention
on two genes within the set of 15 highly connected interactions,
CDC11 and SHS1, for two reasons. First, overexpression of each of
CDC11 and SHS1, which cause moderately impaired growth in
wild type cells as previously reported [35,46], was toxic to six of
the seven non-essential NuA4 deletion mutants (Figure 1C). Only
one other gene in the SDL network, RPN8, displayed this same
degree of SDL interconnectivity with NuA4. Secondly, CDC11
and SHS1 encode proteins that function within a single complex;
along with CDC3, CDC10 and CDC12, these genes encode the five
mitotic septin proteins in yeast. Septins are highly conserved GTP-
binding proteins that form hetero-octameric protein complexes
localized to the bud neck in yeast [38,47,48]. Notably, overex-
pression of CDC11 and SHS1 was lethal to the NuA4 acetyltrans-
ferase-deficient mutant cells eaf1D and yng2D (Figure 1D),
suggesting the acetyltransferase activity associated with the full
NuA4 complex is required to buffer the effects of SHS1 and
CDC11 overexpression. However, the toxic effects of septin gene
overexpression are specific, as neither CDC10 nor CDC12
overexpression resulted in a SDL phenotype with any NuA4
non-essential deletion mutant (Figure 1D and data not shown).
The numerous SDL interactions between non-essential NuA4
mutants and CDC11 and SHS1 suggest a role for NuA4 in the
regulation of septin protein function.
The elongated bud morphology of eaf1D cells is
dependent on Swe1
A hallmark phenotype associated with mutations in septin genes
and their regulators is the development of elongated buds [49,50],
which results from activation of the Swe1-dependent morphogen-
esis checkpoint [51]. Briefly, this checkpoint coordinates mitotic
progression and bud growth through the Swe1 kinase, which
inhibits mitosis via phosphorylation and inactivation of the mitotic
Cdk1 (Cdc28). As a consequence, cells accumulate in G2/M with
hyper-elongated buds due to an inability to switch from apical to
isotropic growth. We reasoned that if NuA4 regulates septins, then
NuA4 mutants might display Swe1-dependent bud morphology
defects. To test this, we assessed bud morphology of wild type and
eaf1D cells. We discovered that ,25% of EAF1 deletion mutants
displayed elongated buds as compared to wild type cells and
that inactivation of the morphogenesis checkpoint via deletion of
SWE1 partially suppressed both the elongated bud morphology
(Figure 2A) and temperature sensitivity of eaf1D cells (Figure 2B).
Conversely, constitutive activation of the checkpoint induced by
overexpression of SWE1 was lethal to eaf1D cells (Figure 2C). This
data suggests that one of the defects associated with eaf1D cells is
activation of the morphogenesis checkpoint. As these phenotypes
are shared with septin mutants and their regulators, this supports a
role for NuA4 in septin regulation.
Acetyltransferase-deficient NuA4 mutants have defects in
septin dynamics
As septin misorganization or mislocalization is one of the
cellular defects that can activate the morphogenesis checkpoint
[51], we next examined septin localization in NuA4 deletion
mutants. During the cell cycle, septins adopt two predominant
structures: a ring that assembles at the incipient bud site in early
G1, and an hourglass-shaped collar that develops upon bud
emergence. Just prior to cytokinesis, the collar splits into two rings
that are inherited by the mother and daughter and disassembled
following cytokinesis, thereby resetting the cycle [38,47,48]. The
transition between the ring and collar relies on structural changes
NuA4 Regulation of Septin Dynamics in Yeast
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bud neck, but the molecular basis is poorly understood [52]. To
explore the role of NuA4 in septin regulation, using time-lapse
fluorescence microscopy, we examined the localization of Cdc11-
GFP in both wild type and eaf1D cells. In wild type cells, Cdc11-
GFP localized as described above in all cells examined (Figure 3A
and Table 1). However, we discovered a defect in septin
localization in 24% of eaf1D cells in this analysis (Figure 3B, C,
D and Table 1). The major defect, observed in 19% of eaf1D cells,
occurred at the ring-to-collar transition, coinciding with bud
emergence. Specifically, while formation of the septin ring
appeared normal in these cells, rather than re-organizing into a
collar structure upon bud emergence, Cdc11-GFP diffused into
the bud. Next, Cdc11-GFP either assembled into a new ring at the
bud tip and a new bud emerged, or it remained diffusely localized
near or in the bud tip. In both cases the cells developed elongated
buds, consistent with our observations above. Interestingly, in
some of the eaf1D cells with septins mislocalized into the bud tip,
the defect was corrected as Cdc11-GFP re-localized to the bud
neck followed by collar splitting and cell division (Figure 3B). A
second less prominent defect we observed in only 5% of eaf1D cells
was the misorganization of Cdc11-GFP to one side of the bud neck
upon bud emergence (Figure 3D); while bud morphology
appeared largely normal, over time the Cdc11-GFP re-structured
into a collar that spanned the bud neck, albeit lacking the crisp
structure of wild type cells, and the cells eventually divided. We
also found that 11% of eaf1D of cells failed to assemble a new
septin ring one hour or more post-cell division (Table 1). While
this suggests a possible defect in septin ring assembly, given the
slow progression of eaf1D mutants through the cell cycle in this
experiment (time to complete cell division ranged from ,3t o
6 hours), it cannot be ruled out that that these cells would have
eventually developed a new septin ring. As overexpression of
CDC11 and SHS1 impaired the fitness of almost every non-
essential NuA4 deletion mutant (Figure 1C), we also examined
Cdc11-GFP localization in the remaining six non-essential NuA4
deletion mutants and found that only yng2D mutants exhibited
defects similar to eaf1D cells (Figure S1). As Yng2 is the only
other non-essential subunit required for Esa1 catalytic activity in
vivo [9], this work indicates that NuA4 acetyltransferase activity
is required for faithful septin dynamics, in particular during the
re-organization of septin filaments into the collar upon bud
emergence.
NuA4 regulation of septin dynamics occurs
independently of the histone H4 N-terminal tail
It was previously reported that both Esa1 and the N-terminal
tail of histone H4 become essential when the morphogenesis
checkpoint is constitutively activated [53,54]. This suggests the
basis of these genetic interactions might lie in altered chromatin
structure or transcriptional misregulation derived from defects in
histone H4 modifications. To test the hypothesis that histone H4
acetylation by NuA4 controls septin dynamics in vivo, we examined
Cdc11-GFP localization and bud morphology in cells expressing a
plasmid-borne copy of wild type or N-terminal deletion mutant
(amino acids 4 to 19) (H4-DN) as the sole source of histone
Figure 2. Elongated buds and temperature sensitivity of eaf1D
cells is partially suppressed by deletion of SWE1. (A) eaf1D
mutants exhibit elongated buds that can be suppressed by deletion of
the Swe1 morphogenesis checkpoint. Wild type (YKB779), eaf1D
(YKB42), swe1D (YKB1807), and eaf1D swe1D (YKB1266) cells were
grown to mid-log phase in YPD at 25uC, fixed, and bud morphology was
scored for at least 100 cells of each type. The average of three replicates
is presented. (B) Deletion of SWE1 rescues the temperature sensitivity of
eaf1D cells. The strains used in (A) were spotted in ten-fold serial
dilutions and incubated at the temperatures indicated on YPD plates.
(C) Overexpression of SWE1 is toxic to eaf1D cells. Wild type (YKB779),
eaf1D (YKB42), pGAL-SWE1 (YKB1648), and eaf1D pGAL-SWE1 (YKB1806)
cells were spotted on complete medium (yeast extract, peptone) in 10-
fold serial dilutions containing glucose or galactose as the sugar source
at 25uC for 2 days.
doi:10.1371/journal.pone.0025336.g002
Figure 1. The NuA4 synthetic dosage lethal interaction network identifies a novel link with septin proteins. (A) The NuA4 SDL genetic
interaction network. Black nodes represent NuA4 genes, which are organized based on sub-complexes within the NuA4 complex (EAF1: complex
integrity; EAF3, EAF5, EAF7, YAF9: recruitment module; EAF6, YNG2: Piccolo NuA4, PicNuA4). Interacting genes are represented by nodes colour-coded
according to functional annotation as listed in the legend, and organized into groups based on the number of interactions with NuA4 sub-complexes.
For instance, nodes located in the centre of the figure interact with one or more NuA4 mutants from each of the three sub-complexes. Small nodes
denote genes that interact with only one NuA4 mutant. Edges indicate SDL or SDS genetic interactions (see also Table S3). (B) Comparison of the
NuA4 SDL and SL genetic interactions identified by genome-wide screens for the five non-essential NuA4 subunits EAF1, EAF3, EAF5, EAF6, EAF7 (see
Table S4 for the compiled list of SL interactions). (C) Overexpression of the septin genes CDC11 and SHS1 (yellow nodes) is toxic to most non-essential
NuA4 deletion mutants (black nodes). Black and grey edges represent SDL or SDS interactions, respectively. (D) Overexpression of the septin genes
CDC11 and SHS1 cause death in the absence of EAF1 or YNG2. Isogenic wild type (YKB779), eaf1D (YKB44) and yng2D (YKB494) cells containing
galactose-inducible, plasmid-borne copy of galactose inducible CDC10, SHS1, CDC11, CDC12, or an empty vector control (pRS416) were spotted in
serial ten-fold dilutions on minimal media lacking uracil and containing either glucose or galactose at 25uC for 3 or 5 days, respectively.
doi:10.1371/journal.pone.0025336.g001
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oblong in both mothers and buds than their wild type counterparts
(Figure 4A and B), however, in the vast majority of mutants cells
(98.3%), septins localized to the bud neck as in wild type (100%).
We did observe a few cells with ectopically localized Cdc11-GFP
in addition to the correctly formed ring or collar, but in only 1.7%
of H4-DN cells were septins mislocalized to the bud tip (Figure 4C).
As the phenotypes we observed in H4-DN mutants were largely
distinct from eaf1D mutants, this suggests NuA4 is not regulating
septin dynamics and bud morphology through the acetylation of
the N-terminal tail of histone H4 or altered chromatin structure.
As NuA4 acetylates the histone H2A variant Htz1, we also
examined Cdc11-GFP localization in cells lacking HTZ1 and
discovered these cells were indistinguishable from their wild type
counterpart (data not shown). Together, these data indicate that
the role of NuA4 in septin dynamics occurs independently from its
primary histone acetylation targets, potentially through the
acetylation of non-histone proteins.
Septin proteins are acetylated in vivo and in vitro by
NuA4
As other studies have shown that SDL screens can identify targets
of kinases [35,37], the SDL interactions between NuA4 mutants
and CDC11 and SHS1 encouraged us to directly test whether one or
more septin proteins are acetylated in vivo. To this end, septin
protein complexes were purified through endogenously tagged
Cdc11-GFP and Shs1-GFP. Septin hetero-octamers contain two
each of Cdc3, Cdc10, and Cdc12, and further one or two of Cdc11
and/or Shs1 [56]. Western blot analysis of the isolated septins using
two different anti-acetyl lysine antibodies suggested that Cdc10 and
Shs1 are acetylated in vivo (Figure 5A). While both antibodies
recognized Shs1, only one recognized Cdc10, indicating the
possibility of variability in epitope recognition. Notably, considering
the ratio of the acetylation signal to the quantity of protein purified
(assessed by silver stain) the Shs1-GFP protein was much less
acetylated in comparison to the untagged Shs1 protein that co-
purified through Cdc11-GFP. (Figure 5A, a-Ac K Cell Sig.). To
assess the in vivo dependence of septin acetylation on NuA4 activity,
we evaluated the acetylation status of Shs1 and Cdc10 through
Western blot in strains harboring either a wild type or thermo-
sensitive ESA1 allele, esa1-L254P mutant [11]. The protein encoded
by esa1-L254P is catalytically inactive at the restrictive temperature
of 37uC [11]. Following immunopurification through Cdc11-GFP,
we discovered that while acetylation of Cdc10 and Shs1 was
unchanged at 25uC, a reduction in acetylation on both proteins was
observed specifically in the esa1-L254P strain background in cells
grown at 37uC (Figure 5B). This result indicates that acetylation of
both Cdc10 and Shs1 is partially dependent on Esa1 in vivo.
Supporting the possibility that additional KATs may regulate septin
dynamics through the acetylation of septin proteins, we have
discovered that two additional yeast KAT mutants, gcn5D [57] and
eco1-203 [58], also have defects in septin localization, although not
as severe as those observed in eaf1D cells (Figure S2). Interestingly,
through mass spectrometry we discovered that components of the
actin cytoskeleton, including actin itself (Act1) and two members of
actin cortical patches, Abp1 and Crn1 [59], co-purify with Cdc11-
GFP in the esa1-L254P strain background at 37uC. Co-purification
of Act1 with septins was also detected in the acetyltransferase-
deficient eaf1D and yng2D strain backgrounds (data not shown). To
specifically examine the ability of NuA4 to acetylate septin proteins,
Table 1. Quantification of defects in eaf1D cells.
Morphology WT eaf1D
Bud Septin (n=15) (n=43)
Normal Normal 100% 65%
Elongated Mis-localized in bud 0% 19%
No bud Ring did not re-assemble
(.1 hour)
0% 11%
Normal Localized to one side of neck 0% 5%
Using time lapse imaging of cells expressing Cdc11-GFP in the presence (WT
(YKB1312)) or absence of EAF1 (eaf1D (YKB1310)), mother cells (immediately
after cytokinesis) were followed through a cell cycle and bud and septin
morphology was scored. Images were collected at five or fifteen minute
intervals for wild type and eaf1D cells, respectively, at room temperature.
doi:10.1371/journal.pone.0025336.t001
Figure 4. Septin localization defects of eaf1D cells are distinct
from histone H4 tail mutants. Cells expressing Cdc11-GFP, in which
the sole source of histone H4 was expressed from a plasmid encoding a
wild type (WT H4, YKB1260) or a mutant gene (H4-ND, YKB1261), were
grown to mid-log phase at 25uC in YPD medium supplemented with
adenine. Cells were fixed with paraformaldehyde prior to imaging by
fluorescence microscopy. H4-ND encodes a protein in which amino
acids 4 to 19 are deleted. Representative images of WT H4 and H4-DN
cells are shown in (A) and (B), respectively. The yellow arrow points to
an ectopic septin ring and the red arrows point to cells with septin in
both the bud tip and neck. (C) Quantification of the defects observed
for Cdc11-GFP localization in the cells represented in (A) and (B). The
experiment was performed in triplicate scoring more than 100 cells in
each replicate and the average is presented.
doi:10.1371/journal.pone.0025336.g004
Figure 3. eaf1D cells have defects in septin dynamics. Time lapse imaging of cells expressing Cdc11-GFP in the presence (WT, YKB1312) or
absence of EAF1 (eaf1D, YKB1310). Cells were grown to mid-log phase in YPD supplemented with adenine at 25uC, and transferred onto synthetic
complete agarose pads for imaging at room temperature. Images were collected at five or fifteen minute intervals for wild type and eaf1D cells,
respectively. Representative images of cells over time are shown in panel (A) for wild type cells and panels (B–C) for eaf1D cells. Red arrows point to
septins mislocalized into the bud. The yellow arrow points out initially mislocalized septins that re-localize to the bud neck, followed cell division. (D)
Images of three different eaf1D cells exhibiting septins misorganized to one side of the neck. Quantification of live cell imaging is presented in Table 1.
doi:10.1371/journal.pone.0025336.g003
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from yeast (Cdc10- Cdc11- and Shs1-TAP) using radiolabeled
acetyl coenzyme A. This analysis confirmed that in addition to
acetylatingitself,NuA4 wascapableofacetylating Cdc3,Cdc12and
Shs1 in vitro, however acetylation on Cdc10 was not detected
(Figure 5C). As septins were immunopurified from wild type yeast
cells, it is possible that Cdc10 was fully acetylated prior to the assay,
thereby precluding additional in vitro acetylation by NuA4. Finally,
to identify the modified lysine residues, septins were purified
through endogenously TAP-tagged Cdc11-TAP or Shs1-TAP, and
mass spectrometry was performed. To enrich acetylation levels
within the immunopurified septins, half of each immunopurified
sample was subjected to an in vitro KAT reaction using highly
purified NuA4 [13] and acetyl coenzyme A. Eighteen lysine
acetylation sites on four septin proteins (Table 2 and Table S5), as
Figure 5. Septin proteins are acetylated in vivo and in vitro. (A) Cdc10 and Shs1 are acetylated in vivo. Septin protein complexes were
immunopurified through the GFP tag and separated by SDS-PAGE (7.5%) in cells expressing Cdc11-GFP (YKB1312), Shs1-GFP (YKB1878), or an
untagged strain (YKB780; no tag). Left: silver stain to indicate the relative migration of septins. Right: Western blots using anti-acetyl lysine (a-Ac K)
antibodies from Cell Signaling (Cell Sig.) or Upstate. Intervening lanes are cropped. (B) Acetylation of Shs1 and Cdc10 is dependent on Esa1 KAT
activity in vivo. Septin proteins were immunopurified from cells grown at 25uCo r3 7 uC for four hours through Cdc11-GFP in a wild type ESA1
(YKB1312) or mutant esa1-L254P background (YKB1804). Immunopurified (IP) products and whole cell extract (WCE) samples were separated by SDS-
PAGE, silver stained or subjected to Western blot analysis. Shs1 and Cdc10 acetylation was assessed using antibodies in (A). Expression and
immunopurification of Cdc11-GFP and Act1 was assessed with a-GFP and a-actin antibodies. Esa1 catalytic activity was assessed through histone H4
acetylation levels (a-Ac K H4). Glyceraldehyde-6-phosphate dehydrogenase (a-G6PDH) is a loading control. Red star: actin. This figure is representative
of five experimental replicates. Intervening lanes are cropped. (C) NuA4 acetylates septins in vitro. In vitro KAT assays were carried out on septins
immunopurified through Cdc10-TAP (YKB1443), Cdc11-TAP (YKB1455), or Shs1-TAP (YKB1466), relative to an untagged control (YKB779; no tag) using
NuA4 purified from yeast and [
3H]-acetyl coenzyme A. Reactions were separated by SDS-PAGE (7.5%), visualized by Coomassie staining, treated for
fluorography, and visualized on film. The migration of NuA4 subunits is shown on the left. Acetylation of chicken core histones monitors NuA4’s
activity in vitro. Plus sign: shift in mobility on the gel due to the presence of the calmodulin binding peptide. Red circles: septin proteins that are
acetylated in vitro. This figure is representative of two experimental replicates.
doi:10.1371/journal.pone.0025336.g005
Table 2. Acetylated lysine residues on septin proteins.
Septin
Protein
Coverage Acetylation site
Cdc3 77% K4, K137, K316*
Cdc10 60% K73, K78, K128, K166
Cdc11 73% ----
Cdc12 81% K193*, K251, K338*
Shs1 62% K57, K82*, K204, K352, K443*, K478, K488*, K536
*= Acetylation site was only identified in sample subjected to NuA4 in vitro KAT
assay.
doi:10.1371/journal.pone.0025336.t002
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identified. While a few acetyl lysine sites were unique to the NuA4 in
vitro KAT assay samples (Cdc3 K316; Cdc12 K193 and K338; Shs1
K82, K443, K488), the rest were also identified in the untreated
samples, confirming that septins are acetylated in vivo. In summary,
these data demonstrate that at least four of the five septin proteins
are acetylated in vivo, implicate NuA4 in the acetylation of Shs1 both
in vitro and in vivo, and indicate Cdc10 acetylation relies on Esa1
activity in vivo.
Unacetylable shs1 mutants have bud morphology and
septin localization defects similar to NuA4 mutants
We next sought to establish a direct cause-and-effect relation-
ship between septin acetylation and the defects in septin
organization and localization observed in NuA4 mutants. To this
end we tested whether loss of septin acetylation, achieved by
mutating acetylated lysine residues on septin proteins to arginine,
could re-capitulate the phenotypes observed in the NuA4 mutants.
We focused our efforts on Shs1 for multiple reasons. First, previous
studies have established the use of SDL screens for the
identification of enzyme-substrate relationships [35,37,60]; as
overexpression of SHS1 caused SDL phenotypes in NuA4 non-
essential deletion mutants, this predicts that Shs1 is a target of
NuA4. In agreement with this, we found that Shs1 is the most
abundantly acetylated septin protein as detected by mass
spectrometry (Table 2), and a target of NuA4 both in vitro and in
vivo (Figure 5). We initially cloned a C-terminally epitope-tagged
version of SHS1 (SHS1-HA3; encoding three copies of the
hemagglutinin epitope) into a low copy plasmid under the control
of the endogenous SHS1 promoter. However, when septin protein
complexes were purified through Cdc11-GFP in exponentially
growing cells, we discovered that the Shs1-HA3 fusion protein,
whether expressed from a plasmid or the endogenous genomic
locus (Figure 6A, lanes 2 and 4, respectively), was acetylated to
only a small degree in vivo relative to the untagged, endogenously
encoded Shs1 protein (Figure 6A, lane 3). As Shs1-HA3 co-
migrated with Cdc3, its incorporation into the septin hetero-
octamer was assessed by Western blot. By eliminating the HA3
epitope tag from the SHS1-encoding plasmid, acetylation of Shs1,
immunopurified through Cdc11-GFP, could be restored to the
level observed on the genomically encoded Shs1 (Figure 6B; lanes
1 and 4). This result suggested that the presence of the relatively
small HA3 tag (,3 kDa, 30 amino acids) effectively blocked
acetylation of Shs1 in vivo as detected in this Western blot analysis.
Given the C-terminal location of the HA3 tag, this also indicated
that despite the identification of acetyl lysine residues over the
length of Shs1 (Table 2, Figure 6C), the predominant site(s) of
acetylation might reside close to the carboxy terminus (Figure 6D).
To test the role of the C-terminal tail in Shs1 acetylation, we
subsequently generated a C-terminal truncation in the SHS1
plasmid by deleting the nucleotide sequence encoding the final 66
amino acids of Shs1 (shs1-66D) (Figure 6C and D). In total, the
truncation eliminated eight lysine residues, two of which were
identified as acetyl lysine residues by mass spectrometry (K488 and
K536; Table 2). We discovered that despite incorporation of
truncated Shs1 (shs1-66D) into the Cdc11-GFP immunopurified
septin protein complex to the same degree as wild type Shs1
(Figure 6B silver stain, compare lanes 4 and 5), the acetylation
signal of shs1-66D was completely abolished (Figure 6B, a-Ac K
Western blot, lanes 4 and 5). This suggested that Shs1 acetylation
indeed relies on the C-terminal tail. To assess the contribution of
acetyl lysine residues identified by mass spectrometry to the overall
acetylation status of Shs1, we generated a multi-site shs1 mutant
(‘All-R’), by mutating the majority of these sites (K57, K82, K204,
K352, K443, K478, K488, K536) plus two additional N-terminal
lysines (K16, K19) to arginine. The resulting signal on the ‘All-R’
mutant was unchanged relative to wild type Shs1, indicating that
these lysines do not contribute substantially to the acetylation of
Shs1 immunopurified through Cdc11-GFP (Figure 6B, lane 6). To
specifically test the contribution of C-terminal lysine residues in
Shs1 acetylation, we generated Shs1 plasmids with lysine-to-
arginine point mutations in the eight (8R: K488, K492, K500,
K505, K509, K515, K535, K536) or nine (9R: 8R + K478) C-
terminal most lysine residues. While the All-R mutant indicated
that K478, K488, or K536 are not the exclusive sites of acetylation
in the C-terminus, we included these mutations to account for the
possibility of functional redundancy or partial contribution. Septin
protein complexes were subsequently immunopurified through
Cdc11-GFP and the acetylation status of co-purified Shs1 assessed
by Western blot. In each of the 8R and 9R mutants we observed a
clear and reproducible reduction in acetylation on Shs1 (Figure 6E,
lanes 6 and 7) as compared to the wild type Shs1 (Figure 6E, lane
3). However, the drop in signal was neither complete, as in the
shs1-66D mutant (Figure 6E, lane 5), nor as marked as the
reduction observed on the Shs1-HA3 fusion protein (Figure 6E,
lane 4). If Shs1 acetylation, as detected by this antibody, occurred
exclusively within the C-terminal tail, then the signal on the 8R
and 9R mutants should have been completely ablated. Together,
these results suggest that the primary site(s) of acetylation do not
reside in the C-terminus, but that maximal acetylation of Shs1
depends on the presence of an unperturbed C-terminal tail. In
agreement, cells expressing the 8R or 9R C-terminal Shs1 mutants
were only moderately temperature sensitive as compared to near
lethality of those expressing Shs1-HA3 or shs1-66D (Figure 6E).
Given the loss of acetylation in the shs1-66D and shs1-HA3
mutants, we wondered whether these cells would display septin
defects similar to those observed in NuA4 acetyltransferase
mutants. Thus, using fluorescence microscopy, we examined bud
morphology and septin localization in cells expressing Cdc11-GFP
in which the genomic copy of SHS1 was intact (SHS1), fully deleted
(shs1D), C-terminally truncated (shs1-66D), or fused to an HA3 tag
(shs1-HA3). As expected, cells expressing wild type SHS1 exhibited
normal bud morphology and septin localization in all cells
examined (Figure 6F, SHS1). On the other hand, 100% of cells
completely lacking SHS1 displayed highly elongated, multi-budded
cell morphology, with severely fragmented Cdc11-GFP signal
throughout the cell but concentrated near the bud neck(s)
(Figure 6F shs1D). While the majority of cells in the shs1-66D
population exhibited normal bud and septin morphology, in 40%
of these mutant cells we observed highly elongated buds in which
septins were misorganized at the bud neck in a specific pattern
previously described as resembling ‘parallel bars’ [49] (Figure 6F
shs1-66D). Though acetylation was eliminated from the truncated
shs1-66D protein, this phenotype did not correspond to the defects
observed in eaf1D mutant cells (Figures 3B, C, and D). Shs1 is
heavily post-translationally modified by both phosphorylation [61]
and sumoylation [62] in its C-terminus and a role for the C-
terminal domain of Shs1 has been suggested for septin structural
transitions [56]. We hypothesize that the phenotype observed in
the shs1-66D mutant might be attributable to a combination of
these factors. To specifically examine the consequence of loss of
Shs1 acetylation in an intact protein, we finally examined the bud
morphology and septin localization in cells expressing SHS1-HA3,
on which acetylation is virtually eliminated but in which the C-
terminal tail is intact (Figure 6A and 6E). We discovered that cells
expressing the relatively unacetylable Shs1-HA3 protein had a
phenotype similar to eaf1D mutants, in that 5% of cells examined
displayed elongated buds with septins mis-localized to the bud tip
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eaf1D mutants, all small, unbudded cells contained a correctly
formed septin ring, suggesting that loss of Shs1 acetylation does
not impact this stage of septin organization. Although 5% is a
relatively small proportion of cells, this phenotype is never
observed in wild type cells and as such represents an important
observation. If the sole consequence of fusing an HA3 tag to the C-
terminus of Shs1 is to reduce the level of acetylation on the protein
in vivo (see discussion), this result lends support to the hypothesis
that the acetylation of Shs1 directly impacts septin dynamics.
Discussion
In this work, we performed genome-wide SDL screens to assess
the function of the NuA4 lysine acetyltransferase complex and
uncovered a novel role for NuA4 in septin dynamics. Global SDL
profiling represents a relatively new addition to the yeast
functional genomics toolkit. To date, genome-wide SDL screens
have been applied to assess the function of three kinases [35,37],
and to explore the function of a particular proteolytic degradation
pathway [60]. In agreement with the long-standing observation
that SDL interactions occur between members of the same
pathway [63], global SDL screens have successfully identified
substrates of kinases and the work we present here indicates this
will hold true for predicting the substrates of KATs. In principle,
NuA4 SDL and SL interactions may now be utilized in a
complementary fashion, with SL interactions linking NuA4 to
cellular processes and SDL interactions predicting the specific
pathways in which the complex functions. Interestingly, a
comparison of the number of NuA4 SDL interactions uncovered
in this study (89) to previously published NuA4 genome-wide SL
interactions (.500) (Table S4), suggests that while NuA4 function
buffers a diverse array of cellular processes, it may directly
function in only a handful of pathways.
Here we show for the first time a link between KAT function
and the regulation of septin dynamics (Figure 3; Figure S2).
Specifically, our time-lapse imaging implicates NuA4 function in
the septin structural transition that occurs upon bud emergence, as
some eaf1D cells, though capable of assembling a septin ring at the
incipient bud site, failed to re-assemble septins into a collar. The
most prominent defect observed was the mislocalization of septins
within elongated bud tips, while a minority of cells exhibited
septins misorganized to one side of the bud neck. That we also
observed septin mislocalization within elongated buds in eco1 and
gcn5 mutants cells (Figure S2) suggests common or redundant
regulatory roles for KATs in some aspect of septin dynamics.
These observations support the addition of NuA4 and other KATs
onto the list of proteins already implicated in the ring-to-collar
structural transition, including Cdc42, Cla4, Elm1, Gin4, Bni5,
Bud3, Bud4, Bud5, Bni1, Cln1, and Cln2 [49,64,65]. In general,
the ring-to-collar transition is poorly understood mechanistically as
it is likely regulated by multiple parallel pathways. The fact that
NuA4 mutants (esa1-L254P, eaf1D) display synthetic sickness with
cla4D mutants [13,66] suggests that NuA4 and Cla4 may work in
parallel to promote septin organization. Importantly, in all cases,
similar to eaf1D cells, mutations in these genes result in phenotypes
with incomplete penetrance [49,67,68].
How do NuA4 and other KATs regulate septin dynamics? In
this study we have explored the hypothesis that one pathway
involves the direct acetylation of septin proteins. We have
demonstrated that four septin proteins are acetylated in vivo
(Table 2), that NuA4 is capable of acetylating three septin proteins
in vitro (Figure 5C) and that the acetylation of at least Cdc10 and
Shs1 depend in part on Esa1 function in vivo (Figure 5B). While we
did not identify acetyl lysine residues on Cdc11, given the
interchangeable role described for Cdc11 and Shs1 as the
outermost subunit within hetero-octameric septin protein com-
plexes [56] it is possible that acetylation sites may still be mapped
onto this subunit. Our discovery that septin proteins are acetylated
adds an additional layer of complexity to an already crowded
roster of post-translational modifications (PTMs) on yeast septin
proteins. A plethora of phosphorylation and sumoylation sites have
been identified on multiple septin proteins through the action of a
handful of kinases and one SUMO-conjugating enzyme [52].
Notably, the biological consequences of these modifications, which
have generally proven difficult to dissect, have by-and-large been
linked to septin structural transitions [61,64,69,70,71].
To establish a direct cause-and-effect relationship between
septin acetylation and KAT function, we carried out a mutational
analysis of Shs1. Importantly, we have demonstrated that the
elongated bud and septin mislocalization phenotypes observed in
acetyltransferase-deficient NuA4 mutant eaf1D cells (Figure 3B–D)
can be partially re-capitulated in cells expressing Shs1-HA3, which
displays drastically reduced acetylation levels (Figure 6F). A
number of factors could explain the relatively small effect on
septin localization and bud morphology observed in the Shs1-HA3
fusion mutant. First, given the epitope variability of anti-acetyl
lysine antibodies, (Figure 5A), it is possible the acetylation signal
detected on Shs1 by the Cell Signaling antibody does not
recognize the full complement of acetylation on Shs1. Hence,
though acetylation as detected by Western analysis appears
diminished, additional acetyl lysine residues may still be present
on the Shs1-HA3 protein. An alternative, but not mutually
exclusive, explanation is that acetylation on other septin subunits
Figure 6. Unacetylable Shs1 mutants display defects in bud morphology and septin localization. (A) Shs1-HA3 exhibits decreased
acetylation in vivo. Immunopurified septins were analyzed as in Figure 5. Lanes 1 and 2: Cells expressing CDC11-GFP and lacking genomic SHS1 (D)
transformed with an empty vector (emp, YKB2254), or plasmid encoding SHS1-HA3 (HA3, YKB2255). Lanes 3 and 4: Cells expressing genomic CDC11-
GFP and SHS1 as an untagged protein (+, YKB1312) or SHS1–HA3 fusion protein (HA3, YKB2518). Antibodies are described in Figure 5. (B) C-terminal
truncation abolishes Shs1 acetylation. Lane 1: Cells expressing genomic CDC11-GFP and SHS1 (YKB 1312). Lane 2: Untagged control (YKB780). Lanes
3–6: Cells expressing CDC11-GFP and lacking SHS1 (D) transformed with an empty vector (emp, lane 3, YKB2519), plasmid encoding wild type SHS1
(WT, lane 4, YKB2520), C-terminal shs1 truncation (66D, lane 5, YKB2521), or shs1 lysine-to-arginine mutant (All-R: K16,K19,K57,K82,K204,K443,K478,K488,K536,
lane 6, YKB2523). Intervening lanes are cropped. (Ca n dD ) Schematic outlining Shs1 domains and acetylation sites. Domains are noted on top in black.
Acetylatedlysineresidues identified by mass spectrometry arein red along the bottom. Additionallysines usedin mutational analyses are in black.66D:s it eo f
C-terminal Shs1. (E) C-terminal Shs1 lysine mutations reduce in vivo acetylation and cell fitness. Lane 1: untagged control (YKB780). Lanes 2-7: Cells expressing
CDC11-GFP and lacking SHS1 (D) transformed with an empty vector (emp, lane 2, YKB2519), plasmid encoding wild type SHS1 (WT, lane 3, YKB2520),
C-terminal shs1 truncation (66D, lane 4, YKB2521), C-terminal shs1 lysine-to-arginine point mutants (8R: K488,K492,K500,K505,K509,K515,K535,K536, lane 6,
YKB2747; 9R (8R + K478 lane 7, YKB2748). Representative of three experimental replicates. Bottom panels: strains spotted in ten-fold serial dilutions on YPD
plates. (F) Bud morphology and septin localization in shs1 mutants. Cells were grown at 30uC and fixed. Genomic SHS1 was expressed as wild type (SHS1;
YKB2712), C-terminal truncation (shs1-66D; YKB2713), fusion protein (SHS1-HA3; YKB2518), or deleted from the genome (shs1D; YKB2173). Red arrow:
mislocalized septins within an elongated bud.
doi:10.1371/journal.pone.0025336.g006
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interpretations of the phenotype associated with the loss of
acetylation on Shs1-HA3 exist. For instance, fusion of the HA3 tag
may also interfere with PTM’s such as phosphorylation and
sumoylation on Shs1, thereby mediating the phenotype, which we
hypothesize is the case for the shs1-66D mutant (Figure 6F and
text). Alternatively, while Western blot analysis indicates that
Shs1-HA3 is incorporated into the septin hetero-octamer
(Figure 6A lanes 1 and 3, Figure 6E lane 4), as the fusion protein
co-migrates with Cdc3, whether it incorporates to the same level as
untagged Shs1 cannot be determined from the silver stain. Thus,
the reduced acetylation signal on Shs1-HA3 may be a function of
reduced co-purification with Cdc11-GFP, and the loss of
incorporation into the septin complex may underlie the pheno-
type. In the absence of generating Shs1-directed antibodies, it is
difficult to distinguish these possibilities. However, as the absence
of the C-terminal tail on the shs1-66D does not affect
incorporation of the mutant protein into the hetero-oligomer
(Figure 6B and E, lane 5 in both), and as the interaction of Shs1
with the septin hetero-octamer has previously been shown to occur
through its GTP-binding domain [46], we do not believe this to be
a strong possibility.
What biological role does Shs1 acetylation play? As the
acetylation-incompetent Shs1 mutant proteins co-immunopurify
via Cdc11-GFP (Figure 6B and 6E), this suggests that Shs1
acetylation does not specifically regulate hetero-octamer assembly.
Another possibility is that Shs1 acetylation impacts some aspect of
higher-order septin assembly, achieved through end-on-end
polymerization of septin hetero-octamers. That septin rings form
normally in unbudded eaf1D cells or cells expressing Shs1-HA3
suggests that the specific higher-ordered assembly of hetero-
octamers at this stage of the cell cycle is not impacted by loss of
Shs1 acetylation. On the other hand, our data suggest that both
eaf1D cells (Figure 3B and C) and Shs1-HA3 expressing cells
(Figure 6) display defects in establishing the septin collar,
indicating that either assembly or stabilization of the specific
septin polymers required for the ring-to-collar transition are
impaired [46]. Though the exact role of Shs1 in septin dynamics is
likely pleiotropic, it has been suggested that Shs1 serves as a cap to
hetero-oligomer polymerization rather than propagating assembly
of filaments [46]. If acetylation is required for a capping function
of Shs1, in the absence of acetylation, uninhibited polymerization
may lead to septin mislocalization [46]. Similarly, phosphorylation
of Shs1 has previously been linked to the dynamic behavior of
septins [72], however the exact molecular impact of these PTMs
has yet to be established.
Our work provides the first evidence that KAT function
regulates septin dynamics and is the first characterization of
acetylation on septin proteins. Dissecting the functional conse-
quences of acetylation presents many challenges, including
identifying the biologically relevant sites of acetylation, assessing
temporal changes, and assigning KATs to each site. Importantly,
septin acetylation has also been identified in high throughput
proteomic studies in human cells [4,5]. Intriguingly, at least one
component of the human homolog of NuA4, the Tip60 complex,
is known to localize to the cytokinetic furrow during mitosis [73],
suggesting that KAT regulation of septin dynamics and septin
acetylation is highly conserved. However, our data also indicate
that NuA4 likely impacts additional pathways related to septin
proteins. For instance, in the NuA4 SDL map we identified a
number of genes involved in some aspect of cytokinesis, a process
intimately linked to septin dynamics. This includes two chitin
synthase enzymes, Chs2 and Chs3, that function at the primary
septum and throughout the cell wall respectively [74,75]; the
multifunctional protein phosphatase 1, Glc7, and its regulator
Bni4, that together localize Chs2 to the bud neck [76]; and a
number of proteins involved in both formation and regulation of
the actin cortical patch and cytoskeleton, Arc40, Rvs167, Akl1,
Sla1, and the actin structural molecule itself, Act1 [59]. An
alternative and intriguing role for NuA4-dependent acetylation is
that it may lead to changes in protein-protein interactions. Indeed,
we have discovered that KAT-deficient NuA4 mutants alter
physical interactions between septin proteins and components of
the actin cytoskeleton (Figure 5B). More broadly, acetylome
studies [2,4,5,77] clearly indicate that lysine acetylation is an
abundant PTM, hence it is possible that numerous pathways in
addition to septin proteins may be regulated by NuA4-dependent
acetylation to ultimately regulate septin dynamics and the
successful completion of cytokinesis.
Supporting Information
Figure S1 Cdc11-GFP localization in six non-essential NuA4
mutants. Cells expressing Cdc11-GFP, in which one non-essential
NuA4 gene was deleted (eaf3D (YKB1376); eaf5D (YKB1378);
eaf6D (YKB1379); eaf7D (YKB1381); yaf9D (YKB1383); yng2D
(YKB1385)) were grown to mid-log phase at 25uC in YPD
medium supplemented with adenine. Cells were fixed with
paraformaldehyde prior to imaging by fluorescence microscopy.
Representative images in each stage of the cell cycle are presented.
More than 200 cells were examined for each mutant.
(TIF)
Figure S2 Cdc11-GFP localization in KAT mutants. (A) Bud
morphology and septin localization in KAT mutant strains grown
to mid-log phase at 25uC in YPD medium supplemented with
adenine. Strains include: rtt109D (YKB1672); sas2D (YKB1668);
hat1D (YKB1682); hpa2D (YKB1679); elp3D (YKB1676); sas3D
(YKB1800); spt10D (YKB1796); gcn5D (YKB1664); eco1-203
(YKB2145); eaf1D (YKB1310)). Cells were fixed with paraformal-
dehyde prior to imaging by fluorescence microscopy. At least
hundred cells were counted for each strain. (B) GCN5, and ECO1
mutants have defects in cell morphology and septin localization.
Representative images from (A) are shown.
(TIF)
Table S1 Strains used in this study.
(DOCX)
Table S2 Plasmids generated for this study.
(DOCX)
Table S3 NuA4 SDL Interactions. Detailed scoring of all SDL
and SDS genetic interactions identified for the seven non-essential
NuA4 mutants (eaf1D (YKB44); eaf3D (YKB1162); eaf5D
(YKB658); eaf6D (YKB504); eaf7D (YKB530); yaf9D (YKB464);
yng2D (YKB494)). Overexpression of all interacting genes was also
tested in a wild type background strain (WT (YKB779)). The
scoring legend is at the bottom of the table.
(XLS)
Table S4 NuA4 SL Interactions. A list of published SL genetic
interactions for the five non-essential NuA4 subunits subjected to
genome-wide SDL screening (EAF1, EAF3, EAF5, EAF6, EAF7).
Genes included in the list display an SL interaction with one or
more of these five non-essential NuA4 genes. Interactions were
downloaded from Biogrid (http://thebiogride.org/) May 2011.
(XLS)
Table S5 Acetylated lysine residues on yeast septin proteins. LC-
MS/MS was used to identify acetylation sites on peptides derived
from septin proteins. N-terminal acetylation is indicated by
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proteins were subjected to a NuA4 in vitro KAT reaction with
acetyl coenzyme A prior to LC-MS/MS. Acetylation sites
identified in treated samples are indicated by ‘+ acetyl coA’.
Samples were processed on one of two different mass spectrom-
eters as indicated in the Instrument column. All acetylated
peptides identified in multiple experiments are listed with their
respective peptide scores.
(XLS)
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